Overall, based on these findings, we can reasonably believe that EHDS (> 4000 IU/day) should be preferentially recommended to prevent or improve insulin resistance because this dosage strategy benefits increasing the concentration of serum 25-(OH)-D and reducing the level of CRP in children and adolescents with overweight/obesity. This evidence concerns the gene CRP and Insulin resistance.